Press release
Cancer Biomarkers Market to Reach USD 60.13 Bn by 2034
The global cancer biomarkers market is undergoing rapid transformation, driven by increasing cancer prevalence, the shift toward personalized medicine, and technological advancements in biomarker discovery. Cancer biomarkers are biological molecules found in blood, other body fluids, or tissues that are indicative of a normal or abnormal process, or of a condition or disease like cancer. These markers are revolutionizing oncology by enabling earlier diagnosis, targeted therapies, and improved treatment outcomes.
In 2024, the market reached a value of USD 15.80 billion, and it is projected to grow at a CAGR of 14.30% during 2025-2034, ultimately reaching approximately USD 60.13 billion by 2034. This article presents a detailed overview of the cancer biomarkers market, answering key questions that users are searching for, including segmentation analysis, technological trends, key players, and regional insights.
Cancer Biomarkers Market Overview
The rising incidence of cancer globally, coupled with growing awareness and demand for early detection techniques, is significantly boosting the cancer biomarkers market. Biomarkers are now critical tools in oncology, used for diagnosis, prognosis, monitoring therapeutic responses, and predicting disease recurrence.
Advancements in genomics, proteomics, and bioinformatics have led to the discovery of novel biomarkers, while companion diagnostics have enhanced the clinical utility of these biomarkers, particularly in therapies involving immuno-oncology and targeted cancer drugs.
Get a Free Sample Report with Table of Contents - https://h1.nu/15Oms.
Cancer Biomarkers Market by Type
Protein Biomarkers
Protein biomarkers are the most commonly used in clinical practice due to their high sensitivity and ease of detection through immunoassays. Examples include PSA (prostate-specific antigen) for prostate cancer and HER2 for breast cancer. The high prevalence of cancers like breast and prostate cancer contributes significantly to the demand for protein biomarkers.
Genetic Biomarkers
Genetic biomarkers include DNA, RNA, and epigenetic markers that provide valuable insights into genetic mutations and tumor behavior. They are gaining traction for personalized medicine approaches, particularly in non-invasive liquid biopsy applications. BRCA1/2 mutations, for instance, are commonly associated with hereditary breast and ovarian cancers.
Others
Other biomarker types include circulating tumor cells (CTCs), metabolites, and microRNAs. Though currently less utilized, they represent emerging areas with vast potential in clinical oncology.
Market Segmentation by Cancer Type
Lung Cancer
Lung cancer accounts for the largest share due to its high global incidence and mortality rate. Biomarkers like EGFR, ALK, and PD-L1 are routinely used for patient stratification and targeted therapies.
Breast Cancer
Breast cancer biomarker applications, including HER2, estrogen and progesterone receptors, and BRCA gene tests, are well established and continue to grow with advancements in hormone therapy and immunotherapy.
Leukemia
Molecular biomarkers play a key role in diagnosing and classifying leukemia subtypes. Genetic testing and minimal residual disease (MRD) markers have become essential in monitoring disease progression.
Melanoma
BRAF and NRAS mutations are prominent biomarkers used in melanoma, especially for selecting patients eligible for kinase inhibitors.
Colorectal Cancer
Biomarkers like KRAS, NRAS, and MSI (microsatellite instability) are being employed for prognosis and therapy selection in colorectal cancer patients.
Prostate Cancer
PSA remains the gold standard, but newer biomarkers such as PCA3 and the 4Kscore test are being explored for better diagnostic accuracy and disease monitoring.
Cancer Biomarkers Market by Application
Prognostics
Prognostic biomarkers help predict disease outcome regardless of treatment. They guide clinicians in risk stratification and long-term monitoring strategies.
Diagnostics
Diagnostic biomarkers are widely used for early detection and differential diagnosis of cancer. They play a crucial role in screening programs and improving survival rates.
Research and Development
R&D applications are seeing increased adoption in pharmaceutical and academic settings. Biomarkers are critical for drug discovery, clinical trials, and developing targeted therapies.
Others
Other uses include predicting treatment toxicity, guiding surgical decisions, and post-treatment surveillance.
Read the Full Report with the Table of Contents - https://h1.nu/1abio.
Market Segmentation by Profiling Technology
Omics
Omics technologies-such as genomics, proteomics, transcriptomics, and metabolomics-enable high-throughput biomarker discovery and validation. These platforms have become essential tools in precision oncology.
Imaging
Imaging biomarkers, including PET, CT, and MRI scans, are being integrated with molecular data to improve diagnostic accuracy and real-time monitoring.
Immunoassay
Immunoassays remain a cornerstone for detecting protein-based cancer biomarkers, offering high specificity and sensitivity at relatively low costs.
Bioinformatics
Bioinformatics platforms allow for advanced data analytics, integration of multi-omics data, and identification of novel biomarkers from large datasets. AI and machine learning are enhancing this field rapidly.
Others
Other technologies include lab-on-a-chip, liquid biopsy platforms, and point-of-care testing devices.
Market by End-user
Pharmaceuticals and Biotechnology Companies
These players are major end-users, using biomarkers in drug development, companion diagnostics, and precision medicine initiatives.
Diagnostics and Research Laboratories
These laboratories conduct biomarker-based tests for hospitals, researchers, and patients, acting as a crucial part of the supply chain.
Hospitals
Hospitals use biomarker tests for diagnosis, treatment planning, and disease monitoring. Integration with EHR systems and molecular labs is growing.
Others
Other users include academic institutions, CROs, and regulatory bodies contributing to biomarker validation and clinical studies.
Regional Analysis
North America
North America dominates the market due to a strong healthcare infrastructure, advanced diagnostic technologies, and a high prevalence of cancer. The presence of key players and robust R&D funding further boosts growth.
Europe
Europe is the second-largest market, supported by favorable healthcare policies, cancer screening programs, and growing investments in genomics and precision medicine.
Asia Pacific
Asia Pacific is expected to witness the fastest growth due to rising cancer incidence, improving healthcare access, and increasing awareness of early cancer detection.
Latin America
Although a smaller market, Latin America is seeing growth through public-private partnerships, government initiatives for cancer control, and foreign investment in diagnostics.
Middle East and Africa
Challenges like limited infrastructure and affordability persist, but ongoing development in cancer care and diagnostics is likely to open new opportunities.
Key Companies in the Cancer Biomarkers Market
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Siemens Healthcare Private Limited
PerkinElmer Inc.
Bio-Techne
Hologic, Inc.
Quest Diagnostics Clinical Laboratories, Inc.
Charles River Laboratories
These companies are involved in developing cancer biomarker tests, companion diagnostics, research kits, and integrated platforms. Strategic mergers, partnerships, and product launches are common to maintain market leadership.
Future Outlook
The cancer biomarkers market is poised for significant expansion over the next decade. Technological convergence between omics, AI, and liquid biopsy will drive innovation. Additionally, the growing emphasis on personalized medicine, along with regulatory support for companion diagnostics, will unlock new opportunities for stakeholders.
As more biomarker-based therapies receive regulatory approvals and clinical validation expands, the adoption rate will rise across both developed and developing economies.
Explore More Reports
Electronic Health Records (EHR) Market - https://h1.nu/1abjc.
Implantable Medical Devices Market - https://h1.nu/15On0.
Mexico Clinical Trials Market - https://h1.nu/1abjn.
Allergic Rhinitis Epidemiology Forecast - https://h1.nu/1abjv.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market to Reach USD 60.13 Bn by 2034 here
News-ID: 4135740 • Views: …
More Releases from Expert Market Research
United States Webcam Market Size, Growth & Trends 2025-2034
The United States webcam market has experienced substantial growth in recent years, fueled by the increasing demand for high-quality video communication tools. Webcams, which were once primarily used for video conferencing, have become essential for various applications, including content creation, gaming, online education, and telehealth. The widespread adoption of remote work and digital learning has further accelerated the growth of this market.
In 2024, the U.S. webcam market was valued at…
Precision Medicine Market: A Deep Dive into Its Evolving Landscape
The precision medicine market represents one of the most transformative shifts in modern healthcare. Instead of relying on generalized treatments that assume all patients respond similarly, precision medicine leverages biological, genetic, and lifestyle data to deliver interventions tailored to the individual. This personalized approach is reshaping how diseases are prevented, diagnosed, and managed. Its importance continues to grow as healthcare systems seek more efficient, patient-centered solutions capable of improving outcomes…
Global Industrial Hemp Market: Growth, Trends, and Future Outlook 2034
The global industrial hemp market is on a rapid growth trajectory. In 2024, the market size is expected to reach approximately USD 5.99 billion, and it's projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period from 2025 to 2034. By 2034, the market is set to reach an impressive value of USD 34.16 billion. This growth is driven by the increasing demand for…
Laboratory Information System Market Hits $2.1B, 9% CAGR
Why Is the Laboratory Information System Market Growing So Rapidly in 2024-2034?
The laboratory information system market is undergoing significant expansion due to increasing digitalization in healthcare and growing demand for efficient diagnostic workflow management. As laboratories face rising testing volumes, stricter regulatory requirements, and a growing need for automated sample tracking, the adoption of LIS platforms has accelerated globally.
In 2024, the market reached USD 2.10 Billion, and with a robust…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
